The federal government has ordered 600,000 doses of the treatment, which is meant for high-risk Covid patients early in their illness.
Tag: Eli Lilly and Company
U.S. Officials Limit Anitbody Treatments That Don’t Work on Omicron
New and other treatments remain effective but are reaching doctors in quantities that are no match for the Omicron surge.
F.D.A. Authorizes Eli Lilly Antibody Treatment for Youngest Covid Patients
Doctors have a new option for the youngest patients who are vulnerable to the worst outcomes from Covid.
U.S. Buys 100,000 Doses of an Eli Lilly Antibody Treatment
The government will pay $210 million for the doses, which Eli Lilly will ship by the end of March.
Eli Lilly Claims Drug Prevents Coronavirus Infection in Nursing Homes
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Drug Prevents Coronavirus Infection in Nursing Homes, Maker Claims
A monoclonal antibody protected residents and staff members in facilities where the virus had appeared.
Covid Antibody Drugs Go Unused as Need Soars
While such treatments are promising, their use has been slowed by testing lags, overwhelmed hospitals and a perception the therapies are only for well-connected people.
The Race for a Super-Antibody Against the Coronavirus
A network of scientists is chasing the pandemic’s holy grail: an antibody that protects against not just the virus, but also related pathogens that may threaten humans.
Drug Giants Create Fund to Bolster Struggling Antibiotic Start-Ups
New medicines are desperately needed to treat a growing number of drug-resistant infections, but many companies developing the drugs are short on cash and investments.
An Alzheimer’s Treatment Fails: ‘We Don’t Have Anything Now’
With high hopes, drugs to fight brain plaques were tested in people genetically destined to develop dementia. The drugs failed.